Search the Newsreel

Precision Trading with Wave Life Sciences Ltd. (WVE) Risk Zones

This article from Stock Traders Daily provides a detailed analysis of Wave Life Sciences Ltd. (WVE), highlighting weak sentiment across all horizons supporting a short bias. It outlines institutional trading strategies, including long, breakout, and short positions, with specific entry zones, targets, and stop …

Gilead Sciences (NASDAQ:GILD) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen has upgraded Gilead Sciences (NASDAQ:GILD) from a "Hold" to a "Buy" rating. This upgrade aligns with a "Moderate Buy" consensus among analysts, with an average price target of $158.04. The company recently reported strong quarterly results, exceeding revenue expectations, despite some …

Wall Street Zen Downgrades Kodiak Sciences (NASDAQ:KOD) to Sell

Wall Street Zen downgraded Kodiak Sciences (NASDAQ:KOD) from "hold" to "sell" on Saturday, despite the broader analyst consensus being a "Moderate Buy." The company's shares opened near their 52-week high at $41.35, but Kodiak Sciences reported a larger-than-expected quarterly loss of $1.05 per share. …

IDEAYA Biosciences (NASDAQ:IDYA) Rating Lowered to "Sell" at Wall Street Zen

Wall Street Zen downgraded IDEAYA Biosciences (NASDAQ:IDYA) from "hold" to "sell," despite the broader analyst consensus remaining a "Moderate Buy" with an average price target of $50.12. The company's shares opened at $36.30, and it recently reported a quarterly loss of $1.22 per share, …

TriSalus Life Sciences (NASDAQ:TLSI) Cut to "Sell" at Wall Street Zen

Kingfa Science & Technology (India) standalone net profit rises 101.58% in the June 2026 quarter

Achieve Life Sciences (NASDAQ:ACHV) Stock Rating Lowered by Wall Street Zen

Achieve Life Sciences (NASDAQ:ACHV) recently had its stock rating lowered from "hold" to "strong sell" by Wall Street Zen. Despite this downgrade, the company still holds an average "Buy" rating from other analysts with a consensus target price of $15.00. Achieve Life Sciences, a …

Gufic BioSciences consolidated net profit rises 70.70% in the June 2026 quarter

Alto Neuroscience (NYSE:ANRO) Upgraded to "Sell" at Wall Street Zen

Wall Street Zen upgraded Alto Neuroscience (NYSE:ANRO) from "strong sell" to "sell," despite the broader analyst consensus remaining a "Moderate Buy" with a target price of $36.62. Shares opened at $32.14, near their 12-month high, and the company reported a quarterly loss of $0.65 …

Boston Scientific (BSX), What Is Behind The Latest Investor Attention?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Boston Scientific completes multi year buyback and what it means for investors Boston Scientific …

Indogulf Cropsciences Q1FY27 net profit down 38% YoY; EBITDA margin rises to 6%

Skye Bioscience to acquire Redx Pharma in $125M deal By Investing.com

Skye Bioscience announced its definitive agreement to acquire Redx Pharma through a scheme of arrangement under U.K. law for an approximate $125 million deal. The merged entity will be known as Fibrx Therapeutics Inc., trading on Nasdaq, and will be led by Redx's current …

Wave Life Sciences, Inc.: Revenue and Earnings Analysts Forecasts Revisions | WVE | US94352A1043

Is Boston Scientific’s (BSX) Buyback at Odds with Its Lower 2026 Growth Guidance?

In the June quarter, Boston Scientific completed a share repurchase of 39,922,436 shares, equal to 2.69% of its stock, for US$2,000.11 million under the buyback first announced in December 2020, while quarterly results highlighted underperformance in U.S. Electrophysiology and Watchman alongside lower 2026 organic …

Proficient Auto Logistics (NASDAQ: PAL) raises $75M notes and closes H&A deal

Proficient Auto Logistics (NASDAQ: PAL) successfully raised $75 million through an offering of 5.500% convertible senior notes due 2033 and completed its acquisition of Hansen & Adkins Auto Transport for approximately $130 million. This acquisition positions Proficient Auto Logistics as the largest auto hauler …

TuHURA Biosciences Expect Preliminary Results From IR Study IFX-2.0 With Keytruda for Deep Seated MCC in 1H2027 >HURA

TuHURA Biosciences anticipates preliminary results from its IFX-2.0 study, which combines IFX-2.0 with Keytruda for treating deep-seated Merkel Cell Carcinoma (MCC). These results are expected in the first half of 2027. This study represents a key milestone for TuHURA Biosciences in its development of …

Proficient Auto Logistics (NASDAQ:PAL) Director Acquires $217,200.00 in Stock

Proficient Auto Logistics (NASDAQ:PAL) Director Rohit Lal recently purchased 40,000 shares for $217,200 and an additional 10,000 shares for $55,300, significantly increasing his stake. The stock is trading near its 52-week low and below its moving averages. Analyst sentiment for PAL is mixed, with …

Rohit Lal Purchases 10,000 Shares of Proficient Auto Logistics (NASDAQ:PAL) Stock

Director Rohit Lal recently purchased 10,000 shares of Proficient Auto Logistics (NASDAQ:PAL) stock for $55,300, increasing his total holdings to 71,903 shares. This follows a previous purchase of 40,000 shares for $217,200. The stock is currently trading near its 52-week low, and analyst sentiment …

Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?

On August 11, Gilead Sciences, Inc. (NASDAQ:GILD) exercised its option to exclusively license a preclinical bispecific program targeting solid tumors using MacroGenics, Inc. (NASDAQ:MGNX)'s proprietary TRIDENT platform. The decision triggered a $10 million milestone payment to MacroGenics, injecting momentum into the companies' 2022 collaboration. …

Proficient Auto Logistics (PAL) President and COO purchases 995 shares at $5.55

Proficient Auto Logistics (PAL) CFO purchases 4,000 shares in open-market trade

Bright Minds Biosciences (NASDAQ:DRUG) Issues Quarterly Earnings Results

Bright Minds Biosciences (NASDAQ:DRUG) reported quarterly earnings per share of ($0.17), significantly surpassing analysts' consensus estimate of ($1.28). Following the announcement, shares fell 2.0% to $76.44. Analysts maintain a generally positive outlook on the stock, with an average "Buy" rating and a consensus price …

Proficient auto logistics COO Amy Rice buys $5,522 in stock

Amy F. Rice, COO of Proficient Auto Logistics, purchased 995 shares of the company's stock for $5,522, with the stock trading near its 52-week low. This purchase follows disappointing second-quarter financial results, where the company reported a revenue decline and an adjusted loss per …

Proficient auto logistics CFO buys $22,200 in stock

Proficient Auto Logistics CFO Bradley J. Wright purchased 4,000 shares of company stock for $22,200, at an average price of $5.55 per share, amidst a 25% decline in share price over the past week. This transaction increases his direct holdings to 70,200 shares. The …

Proficient Auto Logistics (PAL) director reports 50K-share open-market buy

Proficient Auto Logistics director Rohit Lal reported open-market purchases of 50,000 shares of the company's common stock. These transactions occurred on August 13 and August 14, 2026, with purchases made at weighted average prices of $5.43 and $5.53 per share, respectively. The filing indicates …

Boston Scientific (BSX) Stock Looks Cheap On Earnings And Fair Value

Is Castle Biosciences Inc (CSTL) a Bargain After 3.0% Drop? GF Value Says Undervalued

Castle Biosciences Inc (CSTL) shares recently dropped 3.0%, leading to a 7.5% decrease over the past week, but GuruFocus' GF Value indicates the stock is slightly undervalued. Despite a strong GF Score of 81/100, driven by high growth potential, the company faces significant challenges …

UBS Maintains Kodiak Sciences(KOD.US) With Buy Rating, Maintains Target Price $80

UBS has reiterated its Buy rating for Kodiak Sciences (KOD.US) and maintained its target price at $80. This indicates a continued positive outlook from the financial institution regarding the company's stock performance.

Perceptive Advisors (NASDAQ: SLDB) details 11.2% beneficial stake and warrant limits

Perceptive Advisors LLC and related entities, including Joseph Edelman, have reported a beneficial ownership of 12,046,579 shares in Solid Biosciences Inc. (NASDAQ: SLDB), representing an 11.2% stake. This includes common stock and pre-funded warrants, with the latter subject to a 9.99% beneficial ownership limitation …

TuHURA Biosciences (NASDAQ:HURA) Posts Earnings Results, Beats Estimates By $0.01 EPS

CSTL (CSTL) files notice to sell 24,908 common shares on NASDAQ

A holder of CSTL common stock has filed a notice of intent to sell up to 24,908 shares on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services. The indicated aggregate market value of these shares is $741,493.72, and they originated from restricted …

Pu’er Lancang Ancient Tea Sets Date to Approve Interim Results

Assembly Biosciences (ASMB) Stock Jumps As Losses Shrink And Revenue Builds

Is Boston Scientific (BSX) Still Undervalued After A 50% Fall?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Boston Scientific stock has fallen about 50% over the past year, yet valuation checks and an intrinsic value estimate based on a Discounted …

Alan Fournier's Bold Q2 2026 Move: Exiting Core Scientific Inc for a -4.6% Portfolio Impact

Alan Fournier, founder of Pennant Capital Management, made significant portfolio adjustments in Q2 2026, as revealed in his latest 13F filing. His most notable move was the complete liquidation of his Core Scientific Inc (NASDAQ:CORZ) stake, impacting his portfolio by -4.6%. Conversely, he initiated …

MCDONALDS CORP (MCD) president Anderson Skye details options, PRSUs and stock